Targeting non-malignant disorders with tyrosine kinase inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd3297.pdf
Reference234 articles.
1. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211–225 (2000). This article gives a comprehensive overview of receptor tyrosine kinase-related signalling and physiological, as well as pathophysiological, implications.
2. Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353, 583–605 (1998).
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
4. Wang, F., Zeltwanger, S., Yang, I. C., Nairn, A. C. & Hwang, T. C. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects. J. Gen. Physiol. 111, 477–490 (1998).
5. Wong, W. S. & Leong, K. P. Tyrosine kinase inhibitors: a new approach for asthma. Biochim. Biophys. Acta 1697, 53–69 (2004).
Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lung Cancer and Interstitial Lung Diseases;Cancers;2024-08-13
2. Hyperglycemia activates FGFR1 via TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes;Acta Pharmaceutica Sinica B;2024-04
3. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023);Eurasian heart journal;2024-03-11
4. Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC);Bone Marrow Transplantation;2023-01-09
5. Epigenetics of Idiopathic Pulmonary Fibrosis;Targeting Epigenetics in Inflammatory Lung Diseases;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3